Skip to main content

Table 4 Relative expression levels of RBM5 in chimeric positive versus chimeric negative tumour samples compared to non- tumour

From: RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours

 

RBM5 (mean ± SD)

Control (S28) (mean ± SD)

normalized RBM5

fold change in tumour compared to non-tumour

Breast Tissue

    

tumour

    

   chimeric transcript (+)

0.073 ± 0.001

0.013 ± 0.001

5.615

35.31

   chimeric transcript (-)

0.041 ± 0.005

0.029 ± 0.004

1.413

8.886

non-tumour

0.017 ± 0.003

0.107 ± 0.005

0.159

1

  1. (+) : chimeric transcript positive, (-) : chimeric transcript negative.